Publicacións en colaboración con investigadores/as de Hospital Xeral Calde (2)

2012

  1. Multicenter, phase II, nonrandomized study of docetaxel plus trastuzumab every 21 days as the primary therapy in metastatic breast cancer overexpressing HER2

    Anti-Cancer Drugs, Vol. 23, Núm. 2, pp. 239-246

2001

  1. Phase II study of irinotecan as first-line chemotherapy for patients with advanced colorectal carcinoma

    Cancer, Vol. 91, Núm. 4, pp. 704-711